(2025)
AIM2 drives inflammatory cell death and monkeypox pathogenesis.
CELLULAR & MOLECULAR IMMUNOLOGY.
22,
12
(2025)
Prolonged immune activation in post-acute sequelae of SARS-CoV-2: neutrophil dynamics and therapeutic insights.
EXPERIMENTAL AND MOLECULAR MEDICINE.
57,
9
(2025)
Can the tumor neural niche be targeted to re-program cancer?.
PLOS BIOLOGY.
23,
7
(2025)
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.
Cell Genomics.
5,
6
(2025)
Spatial omics enters the microscopic realm: opportunities and challenges.
TRENDS IN GENETICS.
1,
1
(2024)
Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes.
SCIENCE ADVANCES.
10,
27
(2024)
A systematic analysis of the landscape of synthetic lethality-driven precision oncology.
Med.
5,
1
(2023)
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
JOURNAL FOR IMMUNOTHERAPY OF CANCER.
11,
10
(2023)
Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
JOURNAL OF INTENSIVE CARE.
11,
1
(2023)
A landscape of response to drug combinations in non-small cell lung cancer.
NATURE COMMUNICATIONS.
14,
1
(2023)
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis.
CANCER DISCOVERY.
13,
7
(2023)
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma.
CELL REPORTS MEDICINE.
4,
2
(2023)
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.
Med.
4,
1
(2022)
CRBN is downregulated in lung cancer and negatively regulates TLR2, 4 and 7 stimulation in lung cancer cells.
CLINICAL AND TRANSLATIONAL MEDICINE.
12,
9
(2022)
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.
CELL DEATH & DISEASE.
13,
4
(2022)
Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti-PD-1 Therapy.
CANCER DISCOVERY.
12,
4
(2022)
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
CANCER DISCOVERY.
12,
11
(2022)
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4.
Translational Oncology.
15,
1
(2021)
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.
NATURE COMMUNICATIONS.
12,
1
(2021)
Synthetic lethality-mediated precision oncology via the tumor transcriptome.
CELL.
184,
9
학술회의논문
(2024)
Accurate Spatial Gene Expression Prediction by integrating Multi-resolution features.
Conference on Computer Vision and Pattern Recognition.
미국
(2024)
Accurate Spatial Gene Expression Prediction by integrating Multi-resolution features.
Conference on Computer Vision and Pattern Recognition.
미국
발전기금
